Clinical Trials Logo

Clinical Trial Details — Status: Completed

Administrative data

NCT number NCT04735094
Other study ID # CT0101
Secondary ID
Status Completed
Phase N/A
First received
Last updated
Start date January 21, 2021
Est. completion date May 17, 2021

Study information

Verified date January 2021
Source Centre hospitalier de l'Université de Montréal (CHUM)
Contact n/a
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

Although balloons appear to improve ultrasound image quality, it's use can be technically difficult for segmental airways because of anatomical limitations to convex probe imaging. Furthermore, it is uncertain whether this leads to a better diagnostic yield. To our knowledge, there are currently no studies showing that the use of balloon improves diagnostic yield with EBUS. We hypothesize that the use of balloon may increase the diagnostic yield by improving ultrasound image quality and reduce the duration of the procedure.The aim of this study is to analyse whether the use of balloon during linear EBUS 1) improves diagnostic yield, 2) reduces the duration of the procedure, and 3) improves ultrasound image quality with increased operator satisfaction in terms of ease of procedure.


Recruitment information / eligibility

Status Completed
Enrollment 46
Est. completion date May 17, 2021
Est. primary completion date May 17, 2021
Accepts healthy volunteers No
Gender All
Age group 18 Years and older
Eligibility Inclusion criteria: - Adults aged =18 years - Patient referred for EBUS guided TBNA of mediastinal LNs - The para-tracheal lymph node (LN) station 4R is planned to be biopsied. Exclusion criteria -Patient referred for EBUS and 4R is NOT planned to be biopsed

Study Design


Related Conditions & MeSH terms


Intervention

Diagnostic Test:
Endobronchial biopsy with the use of a balloon attached to the echo-bronchoscope
A small balloon made of latex can be attached to the tip of echo-bronchoscope which is then inflated with water or saline for better apposition of the echo-endoscope and the airway wall. This may improve ultrasound image quality and aid better visualization of the lymph nodes.

Locations

Country Name City State
Canada CHUM Montréal Quebec

Sponsors (1)

Lead Sponsor Collaborator
Centre hospitalier de l'Université de Montréal (CHUM)

Country where clinical trial is conducted

Canada, 

Outcome

Type Measure Description Time frame Safety issue
Primary Diagnostic yield Diagnostic yield will be calculated separately for each group with and without the use of balloon. Diagnostic yield will be defined as a satisfactory sample with presence of lymphocytes in the aspirate on the final pathology report. In order to minimise the confounding factor in diagnostic yield based on the dimensions of the LN, we chose a single LN station (4R) and patients were sub-dvided into 3 groups based on the size of the LN. 1 year